Page last updated: 2024-08-24

dexfenfluramine and Hypoxia

dexfenfluramine has been researched along with Hypoxia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antier, D; Apfeldorfer, CS; Desbuards, N; Hanton, G; Hyvelin, JM; Rochefort, GY; Schenck, E1
Callebert, J; Drouet, L; Etienne, N; Hervé, P; Humbert, M; Launay, JM; Maroteaux, L; Nebigil, CG; Peoc'h, K; Simonneau, G; Tournois, C1
Antier, D; Bonnet, P; Eder, V; Hanton, G; Hyvelin, JM; Lemaire, MC; Rochefort, GY1
Esteve, JM; Kellermann, O; Launay, JM; Maroteaux, L1
Bader, M; Dempsie, Y; Harmar, A; Herold, N; Loughlin, L; MacLean, MR; MacRitchie, NA; Morecroft, I; Nilsen, M; Peacock, AJ; Welsh, DJ1
Archer, SL; Dall'ava-Santucci, J; Dinh-Xuan, AT; Djaballah, K; Fartoukh, M; Humbert, M; Mercier, JC; Simonneau, G; Weir, KE1

Reviews

1 review(s) available for dexfenfluramine and Hypoxia

ArticleYear
Functions of serotonin in hypoxic pulmonary vascular remodeling.
    Cell biochemistry and biophysics, 2007, Volume: 47, Issue:1

    Topics: Angiotensin II; Animals; Cell Division; Dexfenfluramine; Endothelium, Vascular; Gene Expression Regulation; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Models, Biological; Nitric Oxide; Oxygen; Protein Structure, Tertiary; Serotonin; Signal Transduction

2007

Other Studies

5 other study(ies) available for dexfenfluramine and Hypoxia

ArticleYear
Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
    European journal of pharmacology, 2009, Jan-14, Volume: 602, Issue:2-3

    Topics: Animals; Appetite Depressants; Dexfenfluramine; Enzyme Activation; Female; Gene Expression Regulation; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction; Weight Gain

2009
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension.
    Nature medicine, 2002, Volume: 8, Issue:10

    Topics: Animals; Blood Pressure; Cell Division; Dexfenfluramine; Disease Models, Animal; DNA; Female; Humans; Hypertension, Pulmonary; Hypoxia; Lung; Male; Mice; Organ Culture Techniques; Pulmonary Artery; Pyrimidines; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Vasoconstriction

2002
Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension.
    European journal of pharmacology, 2006, Nov-21, Volume: 550, Issue:1-3

    Topics: Animals; Blood Pressure; Body Weight; Chronic Disease; Dexfenfluramine; Disease Progression; Female; Heart Valve Diseases; Hypertension, Pulmonary; Hypoxia; Lung; Myocardium; Organ Size; Rats; Rats, Wistar; Serotonin Receptor Agonists; Ultrasonography, Doppler; Ventricular Function, Left; Ventricular Function, Right; Weight Gain

2006
Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
    Circulation, 2008, Jun-03, Volume: 117, Issue:22

    Topics: Animals; Dexfenfluramine; Hypertension, Pulmonary; Hypoxia; Mice; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Tryptophan Hydroxylase

2008
Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.
    American journal of respiratory and critical care medicine, 1998, Volume: 158, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Appetite Depressants; Case-Control Studies; Dexfenfluramine; Disease Susceptibility; Female; Fenfluramine; Free Radical Scavengers; Humans; Hypertension; Hypertension, Pulmonary; Hypoxia; Ischemic Attack, Transient; Lung; Male; Middle Aged; Nitric Oxide; Oxidation-Reduction; Physical Exertion; Prospective Studies; Rest; Vascular Resistance

1998